Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
Novartis
Nurix Therapeutics, Inc.
Guardant Health, Inc.
Xencor, Inc.
Context Therapeutics Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Medicenna Therapeutics, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Klus Pharma Inc.
Theratechnologies
Exelixis
Pfizer
EpicentRx, Inc.
Cybrexa Therapeutics
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc
Hoffmann-La Roche
Eli Lilly and Company
Instil Bio
BioEclipse Therapeutics
Multitude Therapeutics Inc.
Pfizer
Xencor, Inc.
MacroGenics
Gilead Sciences
Mitra RxDx, Inc.
Pfizer
NewVac LLC
INSYS Therapeutics Inc
AstraZeneca